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Objectives: Our objectives were (1) to investigate the incidence and cause of
symptomatic superior vena caval anastomotic stenosis and central venous
thrombosis in patients receiving heart or heart-lung transplantation and
(2) to explore percutaneous methods of thrombolysis and endoluminal
intervention to treat these complications. Methods: Review of 1016 cases
revealed three cases of superior vena cava syndrome. Anatomy, surgical
technique, and medical risk factors were examined. Percutaneous treat-
ments, including urokinase thrombolysis, mechanical thrombolysis, bal-
loon angioplasty, and stent placement, were attempted. Results: All three of
these patients underwent transplantation by means of the bicaval anasto-
motic technique. In addition, the diameters of the donor and recipient
cavae were grossly mismatched in all three. Stenoses in all three patients
were successfully treated percutaneously with balloon angioplasty and stent
placement. Treatment of the accompanying large-volume thrombosis was
problematic in these patients, and two had hemorrhagic complications of
urokinase thrombolysis. A mechanical thrombolysis device was used suc-
cessfully in the third patient. Conclusions: Anastomotic stricture and
central venous thrombosis is an uncommon complication of the bicaval
anastomotic technique of heart and heart-lung transplantation. Discrep-
ancy between donor and recipient caval diameters appears to be the major
risk factor. Endoluminal thrombolysis and stenting provides rapid and
enduring relief of symptoms and precludes repeat sternotomy, cardiopul-
monary bypass, and general anesthesia. (J Thorac Cardiovasc Surg 1998;
116:253-61)
On the basis of early success in animal models,orthotopic cardiac transplantation in human
subjects has been customarily performed by
means of the biatrial anastomotic technique first
described by Shumway and coworkers.1,2 This
technique was designed to simplify the vena caval
and pulmonary venous anastomoses. Although its
overall success has been unequivocally proven, a
number of noteworthy complications occur with
regular frequency. Most consequentially, a signif-
icant proportion of these patients have short-term
and long-term arrhythmias, asynchronous and
compromised atrial contraction, atrioventricular
valve incompetence, and other hemodynamically
significant sequelae resulting from sinoatrial node
and conduction pathway disruption and altered
atrial physiology.3-5
More recently, an alternative technique involving
complete resection of the recipient’s right atrium
and primary anastomoses of the superior and infe-
rior venae cavae (SVC and IVC, respectively) has
been shown to reduce the incidence and severity of
many of these complications.6-8 These advantages
are also applicable to heart-lung transplantation. In
addition, complete excision of the donor and recip-
ient hearts facilitates “domino” procedures.9 Nu-
merous centers have adopted the bicaval anasto-
motic technique as a new standard, improving the
likelihood of rapid and complete recovery of normal
physiologic function. However, the necessity of pri-
mary end-to-end anastomoses of the donor and
recipient cavae presents special surgical challenges.
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Anastomotic strictures are a widely known and
well-studied phenomenon in the arena of cardiac
and vascular surgery, and even large central veins
such as the venae cavae are susceptible to this
complication.
We identified three cases of symptomatic SVC
syndrome in patients who underwent heart or heart-
lung transplantation with bicaval anastomoses. All
three patients had anastomotic stenoses as well as
extensive central venous thrombosis. To date, ob-
structive complications of only the SVC have been
encountered, and no instances of IVC obstruction
have been detected. Although hemodynamically sig-
nificant stenoses of the SVC are rare, we are able to
identify the likely causes and thus propose special
surgical precautions in susceptible patients.
In addition, we describe nonsurgical percutane-
ous methods of treating these SVC obstructions
using interventional radiologic techniques. These
techniques preclude the need for repeat sternotomy
or thoracotomy, cardiopulmonary bypass, and even
general anesthesia. Percutaneous techniques, which
include angioplasty, stents, thrombolysis, and
thrombectomy, have long been applied successfully
to the arterial vascular system. More recently, the
applicability to the venous system, particularly in
deep vein thrombosis of the upper and lower ex-
tremities, is being established.10 The success of
percutaneous treatment of central venous obstruc-
tion or occlusion varies depending on anatomic
considerations and on cause of the thrombosis. Our
initial results of percutaneous treatment of anasto-
motic strictures of the SVC have been extremely
encouraging, and as is generally true for treatment
of SVC obstruction from other causes, clinical re-
sponse has been immediate, dramatic, and dura-
ble.11
Clinical summaries
PATIENT 1. A newborn girl was diagnosed with
complex congenital cardiac anomalies, including
double-inlet left ventricle, transposition of the great
vessels, large trabecular ventricular septal defect,
small muscular ventricular septal defect, and hypo-
plastic and dysplastic pulmonic and mitral valves. At
1 day of age, she underwent an uncomplicated
balloon septostomy at the time of diagnostic cardiac
catheterization. At 7 months of age, she underwent
a modified Glenn procedure, and at 3 years 9
months of age, she underwent a modified Fontan
procedure. Although her hemodynamic function
improved with each of these procedures, post-Fon-
tan protein-losing enteropathy with biopsy-proven
lymphangiectasis developed.12
When she was 5 years of age, an orthotopic heart
transplantation was performed, involving takedown
of the modified Glenn shunt and excision of the
modified Fontan repair. End-to-end anastomoses
were performed for the pulmonary artery, aorta,
SVC, and IVC, with a single left atrial button used
for a rim anastomosis. Seven days before the trans-
plantation, a central venous catheter inserted in the
left internal jugular vein became occluded and was
removed, and a Hickman catheter (C.R. Bard, Inc.,
Salt Lake City, Utah) was placed into the right
external jugular vein.
Immediate postoperative recovery proceeded
without major complications. At 2 months, the
patient was noted to have increasing facial swell-
ing and occasional oxygen desaturations. A trans-
esophageal echocardiogram performed on post-
operative day 62 showed thrombus in the SVC, at
which time the Hickman catheter was removed
and a right femoral line was placed. Unfortu-
nately, the patient also passed melenic stool and
had an episode of hematemesis on postoperative
day 62. Endoscopy revealed a small but nonbleed-
ing antral ulcer.
On postoperative day 70, the patient underwent
cardiac catheterization, including pulmonary an-
giography, but no evidence of pulmonary emboli
was found. However, from the femoral approach,
interrogation of the SVC revealed complete occlu-
sion. The occlusion was traversed with a wire and
catheter, and injection of contrast material periph-
eral to the occlusion demonstrated collateral drain-
age through mediastinal and pericardial veins, com-
municating with the pulmonary veins and left atrium
(Fig. 1). Balloon dilatation of the SVC was per-
formed with a 6 mm and then an 8 mm diameter
balloon, but normal flow was not reestablished.
Despite the patient’s recent history of gastrointesti-
nal bleeding, a cautious course of thrombolysis was
attempted. A coaxial multiple side-hole EDM infu-
sion catheter (Mallinckrodt Medical, Inc., St. Louis,
Mo.) and a Sos infusion wire (Cook Inc., Blooming-
ton, Ind.) were placed directly into the thrombus,
and urokinase (Abbott Laboratories, North Chi-
cago, Ill.), 80,000 IU/hr, was infused for a total of 36
hours. During this period, venography was repeated
twice, demonstrating progressive recanalization of
the obstruction.
After 36 hours of lysis, the patient had a recurrent
gastrointestinal hemorrhage as evidenced by melena
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and a nine-point drop in hematocrit value to 23%.
Urokinase was discontinued, and a transfusion
was given. Another venogram showed only partial
reestablishment of flow, and balloon dilatation
was again performed. An area of persistent ste-
nosis measuring less than 3 mm in diameter was
seen even after balloon venoplasty. Finally, a
Palmaz 308 stent (Johnson & Johnson, Warren,
N.J.) was deployed and dilated to 12 mm diame-
ter. This maneuver established rapid antegrade
flow and an angiographically normal-appearing
luminal contour.
The patient’s facial swelling resolved within 48
hours and has not recurred in 32 months of follow-
up. During a myocardial biopsy performed 18
months after treatment, venography confirmed
rapid antegrade flow, and pressure measurements
revealed no gradient. Incidentally, a right iliofemo-
ral deep vein thrombosis developed during the
period of thrombolysis despite therapeutic levels of
heparin. Because of the patient’s history of multiple
venous thromboses, a hematologic workup was pur-
sued, revealing heterozygous factor V Leiden muta-
tion. However, the patient has done well without
long-term anticoagulation therapy.
PATIENT 2. A 47-year old woman had progressive
right heart failure, hypoxemia, and polycythemia
from Eisenmenger’s syndrome, despite apparently
successful surgical repair of an atrial septal defect at
the age of 36 years. The patient underwent heart-
lung transplantation with bicaval anastomoses and
recovered uneventfully until postoperative day 4,
when transient hypotension and hypoxemia devel-
oped. Transthoracic echocardiogram and bronchos-
copy were unrevealing. On postoperative day 8, the
patient was noted to have distended forehead and
neck veins and moderate plethora of the head and
neck, but the central venous pressure, measured
through a left subclavian catheter whose tip was in the
SVC, was only 4 mm Hg.
Venography was performed through a right ba-
silic vein catheter, introduced under ultrasonic guid-
ance. This demonstrated complete occlusion of the
SVC, with nonocclusive thrombus extending into
the right brachiocephalic vein to the level of the
internal jugular/subclavian confluence (Fig. 2). Ad-
ditional access was obtained from the right common
femoral vein, and the SVC occlusion was easily
traversed with wire and catheter. Venography of the
left subclavian vein demonstrated nonocclusive
Fig. 1. Venograms of a 5-year old girl 70 days after heart transplantation for post-Fontan protein-losing
enteropathy. A, Superior venacavogram at time of presentation, demonstrating complete occlusion and
slow drainage through collateral vessels. B, Reestablishment of rapid, in-line flow after catheter-directed
urokinase thrombolysis and placement of a stent.
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thrombus in the left axillary, subclavian, internal
jugular, and brachiocephalic veins.
Thrombolysis was commenced via a Mewissen
multiple side-hole catheter (Meditech/Boston Sci-
entific Corp., Watertown, Mass.), introduced from
the right basilic vein and spanning the right-sided
thrombus, and a Sos infusion wire via the femoral
vein spanning the left-sided thrombus. A total uroki-
nase dose of 170,000 IU/hr was administered for 45
hours. Thrombolytic progress was checked by
venography twice and showed partial recanalization.
Thrombolysis was discontinued when the patient’s
hematocrit value dropped 10 points in 10 hours, and
a chest radiograph revealed a new, large right
Fig. 2. Venograms of a 47-year-old woman 8 days after heart-lung transplantation for Eisenmenger’s
syndrome and atrial septal defect. A, Superior venacavogram demonstrating extensive thrombosis of
central veins and minimal collateral drainage through mediastinal veins. B, Thrombolysis revealed
underlying stenosis, which responded poorly to balloon angioplasty. C, Restoration of flow after placement
of a stent. Note right hemothorax, a complication of thrombolysis.
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pleural effusion. Approximately 800 ml of fresh
hemorrhagic effusion was drained, and the patient
was given a transfusion.
Even after complete lysis of the thrombus, a
persistent stenosis of the SVC was evident on venog-
raphy, 15 mm in length and 3 mm in smallest
diameter. Initial balloon venoplasty did not identify
a tight waist, but the elastic recoil of the region
prevented maintenance of a sufficiently large chan-
nel after dilatation. A Palmaz 308 stent was then
deployed and dilated to 14 mm luminal diameter.
Post-stenting venography demonstrated rapid flow
and a smooth luminal contour. The patient’s venous
distention and plethora resolved within 24 hours.
The woman was discharged on postoperative day 14.
Although no follow-up imaging has been performed,
subsequent myocardial biopsies via a right internal
jugular vein approach have been without incident,
and the patient remains free of symptoms in 30
months of follow-up.
PATIENT 3. A 37-year old man with cystic fibrosis
had oxygen-dependent end-stage respiratory failure.
His medical history was significant for chronic lung
colonization, leading to cerebral abscesses and
chronic seizure disorder at the age of 20 years and
bleeding complications of laparoscopic cholecystec-
tomy and endoscopic sinus surgery, both necessitat-
ing reoperation, at the age of 35 years. The patient
underwent a domino heart-lung transplantation with
bicaval anastomoses and required reexploration of
the right chest wall on postoperative day 1 for
bleeding from collateral vessels.
On postoperative day 9, massive edema of the
head and neck developed. A transthoracic echocar-
diogram revealed no significant cardiac disease, but
echogenic material in the internal and external
jugular veins was identified. Bilateral upper extrem-
ity venograms, performed on postoperative day 11
by means of basilic vein catheters, revealed com-
plete thrombosis of bilateral subclavian, internal
jugular, and brachiocephalic veins, as well as of the
SVC (Fig. 3). Only minimal collateral vessels were
seen in the thoracic wall, suggesting acute thrombo-
sis. Of note, the patient had a ported central venous
catheter (Bard Access, Salt Lake City, Utah) that
had been inserted through the right internal jugular
vein several years before the transplant procedure.
A venogram of the IVC was performed from a
femoral access and showed no abnormalities.
Because of the patient’s recent operations, history
of bleeding complications, and history of intracere-
bral lesions, thrombolysis was deemed unacceptably
risky. Instead, mechanical thrombolysis was per-
formed with an Angiojet device (Possis Medical
Inc., Minneapolis, Minn.).13 This 5F wire-guided
catheter device uses high-pressure jets of saline
solution to develop a Venturi suction effect. Soft
thrombus can be removed without the use of throm-
bolytic agents and with only minor risk of down-
stream embolization. This device was used exten-
sively in this patient’s thrombosed vessels,
reestablishing antegrade flow. However, a critical
stenosis of the SVC persisted, resulting in drainage
via retrograde flow in the azygos vein.
From the left brachial vein access, the tip of the
central venous line in the right internal jugular vein
was snared and pulled out of the SVC into the left
brachiocephalic vein. A total of three overlapping
Palmaz 308 stents were then deployed in the SVC
stenosis and dilated to 14 mm diameter. The central
line tip was then repositioned within the stents.
Final venography demonstrated wide patency and
rapid antegrade flow. The ported central line was
removed the next day. The patient’s head and
neck edema decreased immediately after stenting
and resolved completely within 4 days (Fig. 4).
For the remainder of the hospitalization, the
patient required special attention to gastrointes-
tinal and upper airway complications of cystic
fibrosis and underwent a third thoracotomy for
left hemothorax on postoperative day 26. He was
discharged on day 40 and has remained free of
symptoms referable to SVC obstruction in 12
months of follow-up.
Discussion
Orthotopic cardiac transplantation with the use of
bicaval anastomoses was first proposed by Webb,
Howard, and Neely14 in 1959. However, preference
for complete excision of the recipient heart and
bicaval anastomoses for orthotopic heart and heart-
lung transplantation emerged only with the advent
of domino procedures 30 years later. Even in non-
domino situations, certain advantages of this tech-
nique have made it the procedure of choice at many
institutions. In a prospective, randomized trial in 75
patients comparing the biatrial technique to the
bicaval technique in cardiac transplantation, El
Gamel and associates6 reported numerous signifi-
cant hemodynamic differences. Patients receiving
bicaval anastomoses had lower right atrial pressures,
improved right atrial contractility, fewer atrial tachy-
arrhythmias and decreased need for temporary pac-
ing, lesser incidence of mitral valve incompetence,
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overall shorter hospitalizations, and overall in-
creased short-term survival.
Similarly, in another prospective, randomized
trial of 78 patients, Deleuze and coworkers7 found
decreased atrial arrhythmias and increased early
recovery of sinus rhythm, increased cardiac index,
decreased right atrial and left atrial areas, decreased
tricuspid valve incompetence, and decreased post-
operative pulmonary arterial pressures in patients
receiving bicaval anastomoses. Other retrospective
studies have also found improved left atrial func-
tion,5 improved exercise tolerance and capacity,4 but
no significant difference in ventricular function15 in
patients receiving bicaval anastomoses.
The data for short-term efficacy seem compelling,
but the data for long-term efficacy are still pending.
Specific disadvantages of the bicaval anastomotic
technique are primarily technical and are infre-
quently discussed. Of the few reported complica-
tions associated exclusively with bicaval anastomo-
ses, SVC stenosis has been reported only twice.
Blanche and coworkers16 reported a case of symp-
Fig. 3. Venograms of a 37-year-old man 11 days after domino heart-lung transplantation for cystic fibrosis.
A, Simultaneous bilateral upper extremity venograms demonstrating stasis and central thrombosis with
minimal formation of collateral drainage. B, Repeat venograms after mechanical thrombolysis and
placement of stents. Inflow of unopacified blood from jugular veins causes dilutional effect on brachioce-
phalic opacification.
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tomatic SVC stenosis in a 62-year-old patient who
underwent orthotopic cardiac transplantation for
end-stage ischemic cardiomyopathy. No evidence of
thrombosis of the central veins was seen. This
stenosis required surgical repair 1 month after the
original transplantation, consisting of the interposi-
tion of a 20 mm cryopreserved aortic allograft.
General anesthesia, repeat sternotomy, and normo-
thermic cardiopulmonary bypass were required. The
repair was successful, and the patient remained free
of symptoms in 32 months of follow-up.
In another report, Pedrazzini and colleagues17
described an SVC anastomotic stricture impeding
transjugular myocardial biopsy on postoperative day
14 in a 52-year-old man who required transplanta-
tion for end-stage dilated cardiomyopathy. Al-
though a pressure gradient of 10 mm Hg was
measured across this stricture, the patient remained
free of symptoms with no evidence of thrombosis.
The stenosis was treated percutaneously with bal-
loon angioplasty, effectively reducing the gradient to
4 mm Hg. The patient remained free of signs or
symptoms of venous congestion, despite a moderate
stenosis by angiographic appearance and by pres-
sure measurements.
Our data confirm that stricture of the SVC anas-
tomosis is very uncommon. At Stanford University,
from January 1968 to December 1997, 933 ortho-
topic heart transplantations have been performed
on 866 patients. From March 1981 to September
1997, 154 heart-lung transplantations have been
performed on 150 patients. Since the first bicaval
anastomosis done in 1992, 124 heart transplanta-
tions have been performed by means of the biatrial
technique, 75 heart transplantations have been per-
formed by the bicaval technique, and all 52 heart-
lung transplantations have involved use of the bica-
val technique. In the past year, 35 of 46 procedures
(76%) performed by six surgeons involved bicaval
anastomoses. Our incidence of anastomotic stricture
in patients undergoing bicaval anastomosis is thus 1
of 75 (1.3%) for heart transplants, 2 of 52 (3.8%) for
heart-lung transplants, and 3 of 127 (2.4%) overall.
The major technical difficulty and the most likely
significant risk factor for development of an anasto-
motic stricture is donor-recipient mismatch of caval
diameter. A notable proportion of transplant recip-
ients have had a history of chronic elevated central
venous pressures, tricuspid valve incompetence, anom-
alous venous drainage, or a combination thereof. Over
time, these hemodynamic abnormalities may lead to
dilatation of the central systemic venous drainage,
including the coronary sinus, azygos vein, IVC, and
SVC. All three of our cases, as well as the case
reported by Pedrazzini and the case reported by
Blanche, involved gross mismatches in SVC size.
Technical possibilities for performing a mis-
matched anastomosis include transection of the
donor cava at a bias, using a patch to enlarge the
donor cava, and using a gusset or wedge resection to
Fig. 4. A, Massive plethora of head, neck, and bilateral upper extremities, and distended external jugular
vein caused by SVC syndrome in patient 3. B, Patient’s appearance before discharge 28 days after
thrombolysis. Plethora completely resolved 4 days after thrombolysis and stent placement. (The patient
shaved off his beard.)
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taper the recipient cava. Trento, Blanche, and co-
workers8 have developed a method preserving 1 to 2
mm of a right atrial cuff in the recipient and using
the azygos vein to enlarge the donor caval stump.
They adopted this modification after encountering
their one recognized case of anastomotic stricture,
and subsequently they have not detected any addi-
tional strictures in about 90 patients. Increased
technical complexity and manipulation near the
anastomosis, however, carries the theoretical risk of
disrupting the sinus node or its arterial supply.18
Preserving a right atrial cuff also complicates dom-
ino donation.
Stricture formation in the caudal anastomosis has
never been reported, and gross mismatch of IVC
sizes is almost never seen. The encasement of the
intrahepatic segment, as well as the larger average
size of the IVC, may provide some protection
against dilatation of the native IVC. However, in
orthotopic liver transplantation, stenoses of the IVC
anastomoses do occur. These stenoses may be
treated by percutaneous methods19-21 or avoided by
using a “piggyback” technique that precludes caval
transection and anastomosis.22
Percutaneous treatment of venous obstruction
has mirrored the success of treatment of the arterial
system. Thrombolysis, angioplasty, and stenting of
SVC obstruction has been performed since 1987.23
A large majority of these patients have an underly-
ing malignant tumor that may directly invade, en-
case, or compress the cava, or they have mediastinal
lymphadenopathy that does the same. Other causes
of venous obstruction include mediastinal fibrosis
such as from granulomatous disease or radiation
therapy. A large proportion of these patients have
the added risk factor of central venous lines or
pacemaker leads, which can cause or augment an
erosive, phlebitic, or fibrotic reaction, particularly at
the mobile tip of a long-standing catheter.24
In all three of our cases, caval stenosis was severe
enough to result in central venous thrombosis. Cath-
eter-directed thrombolysis of deep vein thrombosis
has been increasingly accepted, especially in cases in
which an underlying obstruction can be identified
and treated.25 Highest local concentrations of
thrombolytic agents are achieved with infusion cath-
eters and wires that can be buried directly into the
thrombus. Local bleeding complications occur in up
to 12% of cases, most frequently at the site of
venous access.26 Despite the short serum half-life of
thrombolytic agents (10 to 20 minutes for urokinase,
4 minutes for recombinant tissue-type plasminogen
activator27), systemic distribution of these agents
also introduces the risk of remote bleeding compli-
cations. Commonly encountered contraindications
to thrombolytic therapy include recent operation
(within 10 to 20 days), recent gastrointestinal or
other bleeding, intracranial neoplasm, cerebrovas-
cular accident, particularly hemorrhagic stroke, and
concomitant coagulopathy. In two of our three
patients, contraindications existed (recent opera-
tion, recent gastrointestinal hemorrhage), but surgi-
cal reexploration was considered even riskier than a
trial of thrombolysis. Both of these patients had
significant bleeding complications (hemothorax, re-
current gastrointestinal hemorrhage) that resolved
when urokinase was discontinued, but both patients
required transfusions.
Our third patient had multiple contraindications
to thrombolysis, including history of intracerebral
abscesses, history of postoperative bleeding compli-
cations, and recent operation (posttransplantation
day 9). Fortunately, a number of new mechanical
thrombectomy devices that macerate and aspirate
thrombi are now available. These include the Am-
platz thrombectomy device (Microvena, White Bear
Lake, Minn.) and the Angiojet device (Possis Med-
ical Inc., Minneapolis, Minn.). These devices use
mechanical methods to pulverize and aspirate
thrombus, precluding the need for thrombolytic
pharmaceuticals. Both of these devices were orig-
inally designed for use in hemodialysis fistulas, but
applications elsewhere, both in arterial and in
venous systems, are being explored. We present
an example of an especially appropriate applica-
tion of this technology in a patient who was not a
candidate for biochemical thrombolysis, who was
at high risk for surgical reexploration, and who
had an enormous thrombus load large enough to
be life-threatening if embolized into the pulmo-
nary circulation. Further development of these
technologies may find wide applicability in diffi-
cult situations such as postoperative and posttrau-
matic deep vein thrombosis.
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